Table 3. Structurally Validated Type II Inhibitors with a Reported Kinase Activity Profile Mapped onto Their Corresponding PDB Identificationsa.

Yes/No signifies its representation in a particular kinase profile.

Yes/No signifies its representation in a particular kinase profile.